Pharmalex UK Services
Pharmalex UK Services is recorded as a service provider in 1 clinical trial. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 1 of 1 trials · Latest update first
A Phase 2 Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of ARO-APOC3 in Adults with Dyslipidemia
Sponsor Arrowhead Pharmaceuticals Inc.
- Start (EU)
- Latest update
- Estimated end
Operational learnings available3 trial-level findings · Read insights
- Enrollment was restricted to participants who completed the 48-week treatment period in parent studies AROAPOC3-2001 or AROAPOC3-2002.
- Following a 22 November 2022 protocol amendment, participants receiving plozasiran 50 mg were changed to 25 mg every 3 months, and all active participants subsequently received 25 mg every 3 months for the remainder of the study.
- From 25 September 2024, participants could self-administer study drug using a prefilled syringe at the study site under investigator or designated-staff supervision.
These findings describe the trial, not the service provider’s performance or responsibility.
Questions about this trial experience
What services are recorded for Pharmalex UK Services?
The 2026-10-09 snapshot links Pharmalex UK Services to 1 distinct CTIS trials. Recorded services include Trial master file management. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Pharmalex UK Services?
The most frequently recorded therapeutic areas are Metabolic Disorders. Recorded phases include Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Pharmalex UK Services conducted?
The linked trials record locations in 3 countries, including Hungary, Netherlands, Poland. These are trial locations, not confirmed office locations or countries where Pharmalex UK Services delivered services.
What can this page tell me about Pharmalex UK Services's trial experience?
Browse 1 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. 1 trials have operational findings that can inform further due diligence. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Pharmalex UK Services. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Pharmalex UK Services Limited